BibbInstruments

BibbInstruments PEG

The PEG Ratio (Price/Earnings-to-Growth) of BibbInstruments (BIBB.SL) as of Oct 20, 2026 is 10,981.16. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was 5,124.54 — a change of 114.29% (higher).

PEG

10,981.16

YoY

114.29%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of BibbInstruments is 2016 10,981.16 . PEG Ratio (Price/Earnings-to-Growth) of BibbInstruments was 2015 5,124.54 . It decreases by 114.29% higher compared to the previous year.

The BibbInstruments PEG history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PEG
Date
PEG
Jan 1, 2014
499.14 SEK
Jan 1, 2015
5,124.54 SEK
Jan 1, 2016
10,981.16 SEK
The BibbInstruments PEG history
YEARPEGYoY
10,981.16+114.29%
5,124.54+926.67%
499.14—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BibbInstruments Stock analysis

What does BibbInstruments do? BiBBInstruments AB generates revenue through the development and sale of diagnostic instruments for early cancer detection, primarily utilizing its EndoDrill technology platform. The company markets specific products including EndoDrill GI Upper for stomach biopsies, EndoDrill GI Lower for intestinal biopsies, EndoDrill GI Lung for lung biopsies, EndoDrill Therapy for organ displacement procedures, EndoDrill Needle for breast biopsies, and EndoDrill Model X for multiple applications. These instruments are sold to hospitals with endoscopy specialist centers and surgical wards, focusing on Scandinavian countries as their primary market. The company's portfolio targets medical professionals requiring precise diagnostic tools for deep skin tissue analysis and treatment procedures. The business model centers on selling specialized biopsy instruments that enable early cancer diagnosis in various organs. EndoDrill GI Upper, GI Lower, and GI Lung are designed for gastrointestinal and respiratory tract biopsies, while EndoDrill Therapy facilitates treatment procedures involving stents and conductors. EndoDrill Needle specifically addresses breast biopsy needs, and EndoDrill Model X serves as an independent research project covering multiple anatomical areas. All products are distributed through hospital networks specializing in endoscopy and surgery. BiBBInstruments AB's revenue streams are derived from direct sales of its diagnostic instrument portfolio to healthcare institutions. The company focuses on Scandinavian countries for distribution, targeting hospitals with specialized endoscopy centers and surgical departments. The EndoDrill technology platform underpins all products, providing a unified approach to early cancer detection and treatment procedures across different medical specialties. BibbInstruments is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BibbInstruments stock

PEG Ratio (Price/Earnings-to-Growth) of BibbInstruments is 10,981.16 in 2016.

PEG Ratio (Price/Earnings-to-Growth) of BibbInstruments changed from 5,124.54 to 10,981.16, representing a 114.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) BibbInstruments since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s BibbInstruments with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — BibbInstruments

All Key Metrics — BibbInstruments